
Rademikibart Yields Rapid Improvements in Moderate to Severe Uncontrolled Asthma
Rademikibart quickly improved clinical outcomes in patients with moderate-to-severe uncontrolled asthma, including forced expiratory volume in 1 second (FEV1) and clinically important reductions in annual exacerbation rates, according to new data published …